Exemestane vs Primobolan
FDA Approved vs Well Studied
avoid Mechanism-based · 64% Both Exemestane and Primobolan carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Molecular Data
Exemestane Primobolan
Weight 296.40 Da 302.45 Da (base)
Half-life ~24 hours ~10 days (enanthate)
Type Steroidal aromatase inhibitor (irreversible, suicide inhibitor) DHT-derivative steroid (C20H30O2)
Key Benefits
Exemestane
01 Irreversible aromatase inactivation eliminates estrogen rebound upon discontinuation
02 Steroidal structure with mild androgenic activity may offset some low-estrogen side effects
03 Potent estrogen suppression (85-95% reduction in estradiol at full dose)
04 Compatible with tamoxifen (unlike anastrozole, no pharmacokinetic interference)
05 Prevents gynecomastia during testosterone or aromatizable steroid cycles
06 Reduces estrogen-driven water retention, bloating, and blood pressure elevation
07 Oral dosing with once-daily or less frequent administration for cycle support
Primobolan
01 Lean muscle mass preservation during caloric deficits with minimal water retention
02 Does not aromatize to estrogen, eliminating estrogen-related side effects
03 One of the mildest androgenic profiles among anabolic steroids, with reduced risk of acne, aggression, and prostate issues
04 Injectable form is non-hepatotoxic, allowing extended cycle durations
05 Strong anti-catabolic properties through glucocorticoid receptor modulation
06 Immune-enhancing effects at moderate therapeutic doses
07 Quality, keepable muscle gains without the bloated appearance common with aromatizing steroids
08 Compatible with long cycle lengths (16-20 weeks) due to mild overall impact on health markers
Dosing Protocols
Exemestane
12.5mg EOD or 25mg E3D (estrogen management) / Every other day to every 3 days (cycle support); daily (breast cancer)
Primobolan
400-800 mg/week (injectable) or 50-100 mg/day (oral) / 1-2x per week (enanthate) or daily (oral acetate)
Lean Mass Preservation - Cutting 400-600 mg/week 2x per week (split dose)
Lean Bulking 600-800 mg/week 2x per week (split dose)
Female Protocol 50-100 mg/week 1x per week
Side Effects
Exemestane
Joint pain and stiffness (generally less severe than with anastrozole due to mild androgenic activity)
Fatigue and general malaise
Hot flashes or flushing
Mood changes (irritability, flat affect, low mood)
Headache
Increased sweating
Primobolan
Suppression of natural testosterone production (dose-dependent, less suppressive than many other anabolic steroids but still significant)
Hair thinning or accelerated male pattern baldness (DHT derivative -- this is the most commonly reported side effect in susceptible individuals)
Adverse lipid changes, particularly HDL suppression (moderate compared to other anabolic steroids)
Mild acne or oily skin (less pronounced than testosterone or other androgens)
Injection site discomfort from larger oil volumes required at performance doses
Gradual decline in natural testosterone production requiring post-cycle therapy
Contraindications
Known hypersensitivity to exemestane or any excipients
Premenopausal women (not indicated and potentially harmful to reproductive function)
Pregnancy or breastfeeding (teratogenic risk)
Severe hepatic impairment
Pre-existing severe osteoporosis or high fracture risk
Concurrent use with other aromatase inhibitors (anastrozole, letrozole)
Prostate cancer (active or history of hormone-sensitive prostate cancer)
Breast cancer in males or females
Pregnancy or potential for pregnancy (teratogenic risk -- fetal virilization)
Severe hepatic impairment (particularly relevant for oral acetate form)
Known hypersensitivity to metenolone or formulation components
Hypercalcemia
Polycythemia (hematocrit above 54% at baseline)
Uncontrolled cardiovascular disease or severe dyslipidemia
Research Evidence
Exemestane Primobolan
Status FDA Approved Well Studied
References 5 studies 4 studies
Latest — January 2017
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.